Document 0718 DOCN M9610718 TI Self-treatment of female external genital warts with 0.5% podophyllotoxin cream (Condyline) vs weekly applications of 20% podophyllin solution. DT 9601 AU Hellberg D; Svarrer T; Nilsson S; Valentin J; Department of Obstetrics and Gynecology, Falun Hospital, Sweden. SO Int J STD AIDS. 1995 Jul-Aug;6(4):257-61. Unique Identifier : AIDSLINE MED/96056095 AB Sixty women with genital warts were randomly allocated to treatment with either weekly application of 20% podophyllin solution or self-treatment with 0.5% podophyllotoxin cream twice daily for three days in weekly intervals. After a maximum of 4 treatment cycles a final assessment was carried out after 3 months. Primary clearance after termination of treatment was 82% for podophyllotoxin and 59% for podophyllin solution. After excluding relapses at the 3-month follow-up, final clearance for podophyllotoxin (71%) was significantly better (P < 0.05) than that for podophyllin solution (48%). The total frequency of warts eradicated was 94% with podophyllotoxin and 74% with podophyllin solution (P < 0.001). Local adverse effects were generally mild or moderate. Podophyllotoxin cream provides a mode of easy application for women with external genital warts and had in this study a significantly better effect than podophyllin solution. DE Administration, Cutaneous Adolescence Adult Comparative Study Condylomata Acuminata/*DRUG THERAPY Female Follow-Up Studies Genital Diseases, Female/*DRUG THERAPY Human Keratolytic Agents/*THERAPEUTIC USE Middle Age Ointments Podophyllin/*THERAPEUTIC USE Podophyllotoxin/*THERAPEUTIC USE Recurrence Solutions Support, Non-U.S. Gov't CLINICAL TRIAL JOURNAL ARTICLE RANDOMIZED CONTROLLED TRIAL SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).